Global NK1/NK3 Receptor Antagonists Market Growth 2025-2031
Description
The global Hepatitis A Viruses Rapid Testing market size is predicted to grow from US$ 1578 million in 2025 to US$ 2002 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Hepatitis A Virus (HAV) Rapid Test is a point-of-care in vitro diagnostic technique that detects hepatitis A virus antigens or antibodies in human samples (e.g., serum, plasma, whole blood, or stool) within a short time frame (typically 15-30 minutes) using immunological principles such as colloidal gold or lateral flow immunoassay. Its primary purpose is to rapidly screen for acute or past HAV infections. This test is characterized by its simplicity, instrument-free operation, and suitability for primary healthcare settings, emergency scenarios, or infectious disease control in resource-limited areas.
United States market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hepatitis A Viruses Rapid Testing players cover Roche Diagnostics, Abbott Rapid Diagnostics, GSK, Merck, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Hepatitis A Viruses Rapid Testing Industry Forecast” looks at past sales and reviews total world Hepatitis A Viruses Rapid Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Hepatitis A Viruses Rapid Testing sales for 2025 through 2031. With Hepatitis A Viruses Rapid Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis A Viruses Rapid Testing industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis A Viruses Rapid Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis A Viruses Rapid Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hepatitis A Viruses Rapid Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis A Viruses Rapid Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis A Viruses Rapid Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Viruses Rapid Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blood Tests
Non-Blood Tests
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Abbott Rapid Diagnostics
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
Bio-Rad Laboratories
Wondfo
Wantai Bio
Siemens Healthineers
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hepatitis A Viruses Rapid Testing market?
What factors are driving Hepatitis A Viruses Rapid Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis A Viruses Rapid Testing market opportunities vary by end market size?
How does Hepatitis A Viruses Rapid Testing break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Hepatitis A Virus (HAV) Rapid Test is a point-of-care in vitro diagnostic technique that detects hepatitis A virus antigens or antibodies in human samples (e.g., serum, plasma, whole blood, or stool) within a short time frame (typically 15-30 minutes) using immunological principles such as colloidal gold or lateral flow immunoassay. Its primary purpose is to rapidly screen for acute or past HAV infections. This test is characterized by its simplicity, instrument-free operation, and suitability for primary healthcare settings, emergency scenarios, or infectious disease control in resource-limited areas.
United States market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Hepatitis A Viruses Rapid Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Hepatitis A Viruses Rapid Testing players cover Roche Diagnostics, Abbott Rapid Diagnostics, GSK, Merck, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Hepatitis A Viruses Rapid Testing Industry Forecast” looks at past sales and reviews total world Hepatitis A Viruses Rapid Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Hepatitis A Viruses Rapid Testing sales for 2025 through 2031. With Hepatitis A Viruses Rapid Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hepatitis A Viruses Rapid Testing industry.
This Insight Report provides a comprehensive analysis of the global Hepatitis A Viruses Rapid Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hepatitis A Viruses Rapid Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hepatitis A Viruses Rapid Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hepatitis A Viruses Rapid Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hepatitis A Viruses Rapid Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis A Viruses Rapid Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Blood Tests
Non-Blood Tests
Segmentation by Application:
Hospital
Clinic
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche Diagnostics
Abbott Rapid Diagnostics
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
Bio-Rad Laboratories
Wondfo
Wantai Bio
Siemens Healthineers
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hepatitis A Viruses Rapid Testing market?
What factors are driving Hepatitis A Viruses Rapid Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hepatitis A Viruses Rapid Testing market opportunities vary by end market size?
How does Hepatitis A Viruses Rapid Testing break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
132 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for NK1/NK3 Receptor Antagonists by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for NK1/NK3 Receptor Antagonists by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
